# Colony Bankcorp Inc: financial statements, quarterly

CBAN · NYSE · CIK 711669 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cban.md) · [Financials](/companies/cban/financials.md) · [Filings](/companies/cban/filings.md) · [Insiders](/companies/cban/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cban/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [13.0](/filings/0000711669-23-000157.md) | [14.3 d](/filings/0000711669-24-000046.md) | [14.7](/filings/0000711669-24-000061.md) | [14.9](/filings/0000711669-24-000108.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.7](/filings/0000711669-24-000128.md) | [1.5 d](/filings/0000711669-25-000046.md) | [1.4](/filings/0000711669-25-000067.md) | [1.5](/filings/0000711669-25-000145.md) | [1.4](/filings/0000711669-25-000158.md) | [1.4 d](/filings/0000711669-26-000007.md) | [1.7](/filings/0000711669-25-000067.md) | [2.1](/filings/0001104659-26-091111.md) | [1.5](/filings/0000711669-25-000158.md) | [(3.5) d](/filings/0001104659-26-057671.md) | [2.3](/filings/0001104659-26-057671.md) | [2.8](/filings/0001104659-26-091111.md) |
| Net income | $m | [5.8](/filings/0000711669-24-000128.md) | [5.6 d](/filings/0000711669-25-000046.md) | [5.3](/filings/0000711669-25-000067.md) | [5.5](/filings/0000711669-25-000145.md) | [5.6](/filings/0000711669-25-000158.md) | [7.4 d](/filings/0000711669-26-000007.md) | [6.6](/filings/0001104659-26-057671.md) | [8.0](/filings/0001104659-26-091111.md) | [5.8](/filings/0000711669-25-000158.md) | [(13.8) d](/filings/0001104659-26-057671.md) | [8.2](/filings/0001104659-26-057671.md) | [10.9](/filings/0001104659-26-091111.md) |
| Diluted EPS | $ per share | [0.33](/filings/0000711669-24-000128.md) | not reported | [0.30](/filings/0000711669-25-000067.md) | [0.31](/filings/0000711669-25-000145.md) | [0.32](/filings/0000711669-25-000158.md) | not reported | [0.38](/filings/0001104659-26-057671.md) | [0.46](/filings/0001104659-26-091111.md) | [0.33](/filings/0000711669-25-000158.md) | not reported | [0.39](/filings/0001104659-26-057671.md) | [0.51](/filings/0001104659-26-091111.md) |
| Basic EPS | $ per share | [0.33](/filings/0000711669-24-000128.md) | not reported | [0.30](/filings/0000711669-25-000067.md) | [0.31](/filings/0000711669-25-000145.md) | [0.32](/filings/0000711669-25-000158.md) | not reported | [0.38](/filings/0001104659-26-057671.md) | [0.46](/filings/0001104659-26-091111.md) | [0.33](/filings/0000711669-25-000158.md) | not reported | [0.39](/filings/0001104659-26-057671.md) | [0.51](/filings/0001104659-26-091111.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,094](/filings/0000711669-23-000157.md) | [3,053](/filings/0000711669-25-000046.md) | [3,016](/filings/0000711669-24-000061.md) | [3,008](/filings/0000711669-24-000108.md) | [3,065](/filings/0000711669-24-000128.md) | [3,110](/filings/0000711669-26-000007.md) | [3,172](/filings/0000711669-25-000067.md) | [3,116](/filings/0000711669-25-000145.md) | [3,153](/filings/0000711669-25-000158.md) | [3,735](/filings/0001104659-26-091111.md) | [3,721](/filings/0001104659-26-057671.md) | [3,628](/filings/0001104659-26-091111.md) |
| Total liabilities | $m | [2,855](/filings/0000711669-23-000157.md) | [2,798](/filings/0000711669-25-000046.md) | [2,756](/filings/0000711669-24-000061.md) | [2,743](/filings/0000711669-24-000108.md) | [2,789](/filings/0000711669-24-000128.md) | [2,831](/filings/0000711669-26-000007.md) | [2,885](/filings/0000711669-25-000067.md) | [2,822](/filings/0000711669-25-000145.md) | [2,850](/filings/0000711669-25-000158.md) | [3,359](/filings/0001104659-26-091111.md) | [3,340](/filings/0001104659-26-057671.md) | [3,238](/filings/0001104659-26-091111.md) |
| Long-term debt | $m | not reported | [238](/filings/0000711669-25-000046.md) | not reported | not reported | not reported | [248](/filings/0000711669-26-000007.md) | not reported | not reported | not reported | [258](/filings/0000711669-26-000007.md) | not reported | not reported |
| Shareholders' equity | $m | [239](/filings/0000711669-24-000128.md) | [255](/filings/0000711669-26-000007.md) | [260](/filings/0000711669-25-000145.md) | [265](/filings/0000711669-25-000158.md) | [276](/filings/0000711669-25-000158.md) | [279](/filings/0001104659-26-091111.md) | [287](/filings/0001104659-26-091111.md) | [294](/filings/0001104659-26-091111.md) | [302](/filings/0000711669-25-000158.md) | [376](/filings/0001104659-26-091111.md) | [380](/filings/0001104659-26-091111.md) | [390](/filings/0001104659-26-091111.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.5 d](/filings/0000711669-24-000128.md) | [5.8 d](/filings/0000711669-25-000046.md) | [5.0](/filings/0000711669-25-000067.md) | [1.1 d](/filings/0000711669-25-000145.md) | [20.5 d](/filings/0000711669-25-000158.md) | [(3.2) d](/filings/0000711669-26-000007.md) | [17.9](/filings/0001104659-26-057671.md) | [15.8 d](/filings/0001104659-26-091111.md) | [14.4 d](/filings/0000711669-25-000158.md) | [(53.7) d](/filings/0000711669-26-000007.md) | [54.3](/filings/0001104659-26-057671.md) | [9.1 d](/filings/0001104659-26-091111.md) |
| Capital expenditure | $m | [0.9 d](/filings/0000711669-24-000128.md) | [0.6 d](/filings/0000711669-25-000046.md) | [0.1](/filings/0000711669-25-000067.md) | [0.1 d](/filings/0000711669-25-000145.md) | [0.3 d](/filings/0000711669-25-000158.md) | [0.6 d](/filings/0000711669-26-000007.md) | [0.3](/filings/0001104659-26-057671.md) | [0.1 d](/filings/0001104659-26-091111.md) | [0.4 d](/filings/0000711669-25-000158.md) | [0.6 d](/filings/0000711669-26-000007.md) | [0.4](/filings/0001104659-26-057671.md) | [1.0 d](/filings/0001104659-26-091111.md) |
| Dividends paid | $m | [1.9 d](/filings/0000711669-24-000128.md) | [1.9 d](/filings/0000711669-25-000046.md) | [2.0](/filings/0000711669-25-000067.md) | [2.0 d](/filings/0000711669-25-000145.md) | [2.0 d](/filings/0000711669-25-000158.md) | [2.0 d](/filings/0000711669-26-000007.md) | [2.0](/filings/0001104659-26-057671.md) | [2.0 d](/filings/0001104659-26-091111.md) | [2.0 d](/filings/0000711669-25-000158.md) | [2.0 d](/filings/0000711669-26-000007.md) | [2.6](/filings/0001104659-26-057671.md) | [2.5 d](/filings/0001104659-26-091111.md) |
| Share repurchases | $m | [0.0 d](/filings/0000711669-24-000128.md) | [0.0 d](/filings/0000711669-25-000046.md) | [0.0](/filings/0000711669-25-000067.md) | [0.2 d](/filings/0000711669-25-000145.md) | [0.5 d](/filings/0000711669-25-000158.md) | [0.5 d](/filings/0000711669-26-000007.md) | [0.6](/filings/0001104659-26-057671.md) | [1.0 d](/filings/0001104659-26-091111.md) | [0.0 d](/filings/0000711669-25-000158.md) | [0.8 d](/filings/0000711669-26-000007.md) | [1.8](/filings/0001104659-26-057671.md) | [0.0 d](/filings/0001104659-26-091111.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.6](/filings/0000711669-23-000157.md) | [17.6](/filings/0000711669-24-000061.md) | [17.6](/filings/0000711669-24-000108.md) | [17.6](/filings/0000711669-24-000128.md) | [17.6](/filings/0000711669-25-000067.md) | [17.6](/filings/0000711669-25-000145.md) | [17.6](/filings/0000711669-25-000158.md) | [17.5](/filings/0001104659-26-057671.md) | [17.4](/filings/0001104659-26-091111.md) | [17.5](/filings/0000711669-25-000158.md) | [21.2](/filings/0001104659-26-057671.md) | [21.2](/filings/0001104659-26-091111.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,220,965 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091111.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.